Advertisement

SCRIP editor, Mike Ward and contributing editor, John Hodgson discuss the trend of stealth investment and big pharma's foray into rare disease indications.

You need to upgrade your Flash Player!

This web site makes use of the Macromedia Flash player 8.

VIDEO PLAYER by 3b nexus
Advertisement
Advertisement